Tridecapeptide compositions and methods
US4002740A · kind A · utility
16Cited by
0References
6Claims
0Family size
Inventors
Key dates
| Filing date | Aug 21, 1975 |
| Grant date | Jan 11, 1977 |
| Priority date | — |
| Expiry date | Aug 21, 1995 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is disclosed a tridecapeptide of the following sequence: EQU H.sub.2 N--Gly--Glu--Gln--Arg--Lys--Asp--Val--Tyr--Val--Gln--Leu--Tyr--Leu--COOH this tridecapeptide has the capability of including the differentiation of T lymphocytes but not of complement receptor (CR.sup.+) B lymphocytes and thus is useful in a number of therapeutic areas. Also provided are novel intermediate polypeptides and methods of manufacture of the peptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.